Charts DiaMedica Therapeutics Inc.

Stocks

Market Closed - Nasdaq 04:00:00 29/10/2026 HKT			5-day change	1st Jan Change
9.820 ^USD	+13.00%		+13.00%	+23.37%

10-22	DiaMedica Therapeutics Reaches Patient Enrollment Milestone for Phase 2/3 Trial of DM199 in Acute Ischemic Stroke	MT
10-22	DiaMedica Therapeutics Inc. Announces Enrollment Of 200th Patient In Its Pivotal Phase 2/3 ReMEDy2 Trial Of DM199 In Acute Ischemic Stroke	CI

NasdaqUSD

Markets		Quality
Nasdaq	DMAC	Delayed
CBOE	DMAC	Real-time

ProRealTime Chart